Xie et al. showed that circVMP1 levels were upregulated in cisplatin-resistant NSCLC cell lines compared to cisplatin-sensitive cell lines, and were delivered via exosomes to promote NSCLC progression and cisplatin resistance by targeting the miR-524-5p-METTL3/SOX2 axis [27]. The gene discussed is METTL3; the disease is non-small cell lung carcinoma.